We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$3.46B
Cap. Flow %
-1.41%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.64%
2 Healthcare 14.1%
3 Financials 12.4%
4 Consumer Discretionary 12.19%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLO
3126
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$160K ﹤0.01%
1,628
-210
-11% -$18.4K
CBUS icon
3127
Cibus
CBUS
$138M
$157K ﹤0.01%
637
-330
-34% -$73.9K
RMNI icon
3128
Rimini Street
RMNI
$471M
$157K ﹤0.01%
30,479
-19,567
-39% -$83.2K
HTZ
3129
DELISTED
Hertz Global Holdings, Inc.
HTZ
$155K ﹤0.01%
110,000
-486,270
-82% -$1.54M
RVLP
3130
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$154K ﹤0.01%
+22,900
New +$112K
GDP
3131
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$154K ﹤0.01%
21,351
+9,621
+82% +$67.9K
MEC icon
3132
Mayville Engineering Co
MEC
$617M
$153K ﹤0.01%
19,337
-1,510
-7% -$9.26K
XONE
3133
DELISTED
The ExOne Company
XONE
$150K ﹤0.01%
+17,538
New +$140K
PHAS
3134
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$149K ﹤0.01%
32,355
-10,146
-24% -$44.9K
ATCO
3135
DELISTED
Atlas Corp.
ATCO
$146K ﹤0.01%
+19,273
New +$140K
GBL
3136
DELISTED
GAMCO Investors, Inc.
GBL
$145K ﹤0.01%
10,917
FUNC icon
3137
First United
FUNC
$289M
$144K ﹤0.01%
+10,786
New +$153K
MYFW icon
3138
First Western Financial
MYFW
$306M
$143K ﹤0.01%
+10,003
New +$134K
CBD
3139
DELISTED
Companhia Brasileira de Distribuicao
CBD
$142K ﹤0.01%
+10,857
New +$131K
XGN icon
3140
Exagen
XGN
$166M
$141K ﹤0.01%
+11,388
New +$154K
CCO icon
3141
Clear Channel Outdoor Holdings
CCO
$1.23B
$134K ﹤0.01%
128,514
-561,894
-81% -$528K
AGRO icon
3142
Adecoagro
AGRO
$1.36B
$133K ﹤0.01%
30,600
+3,200
+12% +$13.4K
CBAN icon
3143
Colony Bankcorp
CBAN
$467M
$130K ﹤0.01%
11,060
CTOS icon
3144
Custom Truck One Source
CTOS
$2.37B
$130K ﹤0.01%
+32,451
New +$94.4K
TRAK icon
3145
ReposiTrak
TRAK
$159M
$129K ﹤0.01%
+30,484
New +$147K
ABTC
3146
American Bitcoin Corp
ABTC
$471M
0
PAM icon
3147
Pampa Energía
PAM
$4.41B
$124K ﹤0.01%
11,800
PAGP icon
3148
Plains GP Holdings
PAGP
$4.9B
$122K ﹤0.01%
13,676
-918,520
-99% -$8.1M
CSBR icon
3149
Champions Oncology
CSBR
$72.1M
$121K ﹤0.01%
+12,642
New +$108K
GFN
3150
DELISTED
General Finance Corporation
GFN
$115K ﹤0.01%
17,204
-11,327
-40% -$68.8K

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.